COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 1386: Articles 13851-13860  | Next

Understanding the role of memory re-activation and cross-reactivity in the defense against SARS-CoV-2
Denninger, V., Xu, C. K., Meisl, G., Morgunov, A. S., Fiedler, S., Ilsley, A., Emmenegger, M., Malik, A. Y., Piziorska, M. A., Schneider, M. M., Devenish, S. R. A., Kosmoliaptsis, V., Aguzzi, A., Fiegler, H., Knowles, T. P. J.
10.1101/2021.07.23.453352 — Posted: 2021-07-23
PDZ-containing proteins targeted by the ACE2 receptor
Caillet-Saguy, C., Wolff, N.
10.1101/2021.07.23.453470 — Posted: 2021-07-23
A Highly Potent SARS-CoV-2 Blocking Lectin Protein
Ahan, R. E., Hanifehnezhad, A., Sahin Kehribar, E., Oguzoglu, T. C., Foldes, K., Ozcelik, C. E., Filazi, N., Oztop, S., Onder, S. C., Bozkurt, E. U., Ergunay, K., Ozkul, A., Seker, U.
10.1101/2021.07.22.453309 — Posted: 2021-07-23
SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium
Giancotti, F., Wang, Y., Gurrapu, S., Chen, H., Laudato, S., Caggiano, E., Jiang, Y., Ling, H.-H.
10.1101/2021.07.23.453505 — Posted: 2021-07-23
Time trends and factors related to COVID-19 vaccine hesitancy from January-May 2021 among US adults: Findings from a large-scale national survey
King, W. C., Rubinstein, M., Reinhart, A., Mejia, R. J.
10.1101/2021.07.20.21260795 — Posted: 2021-07-23 Discussion: Onsite
The COVID-19 pandemic and child malnutrition in sub-Saharan Africa: A scoping review
Sesito, P., Rodriguez Velasquez, S., Orel, E., Keiser, O.
10.1101/2021.07.21.21260929 — Posted: 2021-07-23
Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines
Natacha, M., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D., Grifoni, A., Sette, A., Siegrist, C.-A., Finckh, A., Lalive d'Epinay, P. H., Didierlaurent, A. M., Eberhardt, C. S.
10.1101/2021.07.21.21260928 — Posted: 2021-07-23
Blockade of Interleukin Seventeen (IL-17A) with Secukinumab in Hospitalized COVID-19 patients - the BISHOP study.
Resende, G. G., Lage, R. d. C., Lobe, S. Q., Medeiros, A. F., Costa e Silva, A. D., Nogueira de Sa, A. T., Oliveira, A. J. A. d., Souza, D., Guimaraes, H. C., Gomes, I. C., de Souza, R. P., de Aguiar, R. S., Tunala, R., Forestiero, F., Bueno Filho, J. S. d. S., Teixeira, M. M.
10.1101/2021.07.21.21260963 — Posted: 2021-07-23
A collaborative maternity dashboard (CoMaND) for the COVID-19 pandemic: a protocol for timely, adaptive monitoring of perinatal outcomes in Melbourne, Australia
Hui, L., Potenza, S., Marzan, M. B., Said, J. M., Palmer, K. R., Whitehead, C. L., Rolnik, D. L., Mol, B. W. B., Sheehan, P. M., Ford, J., Pritchard, N.
10.1101/2021.07.22.21261008 — Posted: 2021-07-23
Herd immunity induced by COVID-19 vaccination programs to suppress epidemics caused by SARS-CoV-2 wild type and variants in China
Liu, H., Zhang, J., Cai, J., Deng, X., Peng, C., Chen, X., Yang, J., Wu, Q., Chen, Z., Zheng, W., Viboud, C., Zhang, W., Ajelli, M., Yu, H.
10.1101/2021.07.23.21261013 — Posted: 2021-07-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).